Longitudinal patterns of penile human papillomavirus detection among Ugandan men: A prospective sampling study.

IF 4.7 2区 医学 Q1 ONCOLOGY
Xinyi Feng, Eshan U Patel, Godfrey Kigozi, Patti E Gravitt, Ronald M Galiwango, Molly R Petersen, Fred Nalugoda, Andrew D Redd, Steven J Reynolds, Thomas C Quinn, M Kate Grabowski, Aaron A R Tobian
{"title":"Longitudinal patterns of penile human papillomavirus detection among Ugandan men: A prospective sampling study.","authors":"Xinyi Feng, Eshan U Patel, Godfrey Kigozi, Patti E Gravitt, Ronald M Galiwango, Molly R Petersen, Fred Nalugoda, Andrew D Redd, Steven J Reynolds, Thomas C Quinn, M Kate Grabowski, Aaron A R Tobian","doi":"10.1002/ijc.70107","DOIUrl":null,"url":null,"abstract":"<p><p>Human papillomavirus (HPV) is a highly prevalent sexually transmitted infection, yet data on HPV dynamics in African male populations remain limited. We conducted a prospective study of 300 human immunodeficiency virus-negative, sexually active Ugandan men enrolled at circumcision and followed every 6 weeks for 6 months. Penile swabs were collected by clinical staff, and HPV DNA was detected using the Roche polymerase chain reaction-based linear array assay at six time points. We estimated both point and cumulative prevalence of any and high-risk HPV, and assessed empirical and bootstrapped absolute and relative differences to quantify bias from relying solely on baseline testing. The baseline prevalence of any HPV was 49.7%, increasing to 66.0% when cumulative results were considered. Among 27 men with swabs with amplifiable viral or cellular DNA at all six visits, 100% tested positive at least once. HPV detection was often transient: only 6.1% of men with any HPV were consistently positive at all visits. Men who were ever HPV positive reported a younger age at first sex and more sexual partners. Single-timepoint testing significantly underestimated HPV prevalence, with relative biases of 24.7% for any HPV and 40.3% for high-risk HPV. Bootstrap analyses showed that reducing absolute bias to below 5% required two visits for any HPV and three for high-risk HPV, whereas achieving relative bias below 5% required three and five visits, respectively. The results remained consistent in sensitivity analyses that excluded pre-circumcision visits. These findings highlight the limitations of cross-sectional HPV testing and emphasize the importance of repeated sampling for accurate surveillance and vaccine impact assessments in male populations.</p>","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":" ","pages":""},"PeriodicalIF":4.7000,"publicationDate":"2025-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/ijc.70107","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Human papillomavirus (HPV) is a highly prevalent sexually transmitted infection, yet data on HPV dynamics in African male populations remain limited. We conducted a prospective study of 300 human immunodeficiency virus-negative, sexually active Ugandan men enrolled at circumcision and followed every 6 weeks for 6 months. Penile swabs were collected by clinical staff, and HPV DNA was detected using the Roche polymerase chain reaction-based linear array assay at six time points. We estimated both point and cumulative prevalence of any and high-risk HPV, and assessed empirical and bootstrapped absolute and relative differences to quantify bias from relying solely on baseline testing. The baseline prevalence of any HPV was 49.7%, increasing to 66.0% when cumulative results were considered. Among 27 men with swabs with amplifiable viral or cellular DNA at all six visits, 100% tested positive at least once. HPV detection was often transient: only 6.1% of men with any HPV were consistently positive at all visits. Men who were ever HPV positive reported a younger age at first sex and more sexual partners. Single-timepoint testing significantly underestimated HPV prevalence, with relative biases of 24.7% for any HPV and 40.3% for high-risk HPV. Bootstrap analyses showed that reducing absolute bias to below 5% required two visits for any HPV and three for high-risk HPV, whereas achieving relative bias below 5% required three and five visits, respectively. The results remained consistent in sensitivity analyses that excluded pre-circumcision visits. These findings highlight the limitations of cross-sectional HPV testing and emphasize the importance of repeated sampling for accurate surveillance and vaccine impact assessments in male populations.

乌干达男性阴茎人乳头瘤病毒检测的纵向模式:一项前瞻性抽样研究。
人乳头瘤病毒(HPV)是一种高度流行的性传播感染,但关于非洲男性人群中HPV动态的数据仍然有限。我们进行了一项前瞻性研究,对300名人类免疫缺陷病毒阴性、性活跃的乌干达男性进行了包皮环切手术,每6周随访一次,持续6个月。临床工作人员收集阴茎拭子,在6个时间点采用罗氏聚合酶链反应线性阵列法检测HPV DNA。我们估计了任何高危HPV的点和累积患病率,并评估了经验和自举的绝对和相对差异,以量化仅依赖基线检测的偏差。任何HPV的基线患病率为49.7%,当考虑累积结果时增加到66.0%。在所有六次访问中,有27名男性的拭子携带可扩增的病毒或细胞DNA, 100%的检测结果至少一次呈阳性。HPV检测通常是短暂的:在所有就诊中,只有6.1%的HPV患者始终呈阳性。曾经HPV阳性的男性初次性行为的年龄更小,性伴侣也更多。单时间点检测明显低估了HPV患病率,任何HPV的相对偏差为24.7%,高危HPV的相对偏差为40.3%。Bootstrap分析表明,将绝对偏差降低到5%以下需要对任何HPV进行两次检查,对高危HPV进行三次检查,而实现相对偏差低于5%分别需要三次和五次检查。在排除包皮环切术前访问的敏感性分析中,结果保持一致。这些发现突出了横截面HPV检测的局限性,并强调了在男性人群中进行重复采样以进行准确监测和疫苗影响评估的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
13.40
自引率
3.10%
发文量
460
审稿时长
2 months
期刊介绍: The International Journal of Cancer (IJC) is the official journal of the Union for International Cancer Control—UICC; it appears twice a month. IJC invites submission of manuscripts under a broad scope of topics relevant to experimental and clinical cancer research and publishes original Research Articles and Short Reports under the following categories: -Cancer Epidemiology- Cancer Genetics and Epigenetics- Infectious Causes of Cancer- Innovative Tools and Methods- Molecular Cancer Biology- Tumor Immunology and Microenvironment- Tumor Markers and Signatures- Cancer Therapy and Prevention
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信